Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

In vitro activity of ceftolozane-tazobactam against Enterobacter cloacae complex clinical isolates with different β-lactam resistance phenotypes.

Robin F, Auzou M, Bonnet R, Lebreuilly R, Isnard C, Cattoir V, Guérin F.

Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00675-18. doi: 10.1128/AAC.00675-18. [Epub ahead of print]

PMID:
29914962
2.

Antibacterial spectrum of a tetrazole-based reversible inhibitor of serine β-lactamases.

Pemberton OA, Zhang X, Nichols DA, DeFrees K, Jaishankar P, Bonnet R, Adams J, Shaw LN, Renslo AR, Chen Y.

Antimicrob Agents Chemother. 2018 May 29. pii: AAC.02563-17. doi: 10.1128/AAC.02563-17. [Epub ahead of print]

PMID:
29844038
3.

Highly labeled methylene blue-ds DNA silica nanoparticles for signal enhancement of immunoassays: application to the sensitive detection of bacteria in human platelet concentrates.

Bonnet R, Farre C, Valera L, Vossier L, Léon F, Dagland T, Pouzet A, Jaffrézic-Renault N, Fareh J, Fournier-Wirth C, Chaix C.

Analyst. 2018 May 15;143(10):2293-2303. doi: 10.1039/c8an00165k.

PMID:
29687126
4.

Colibactin: More Than a New Bacterial Toxin.

Faïs T, Delmas J, Barnich N, Bonnet R, Dalmasso G.

Toxins (Basel). 2018 Apr 10;10(4). pii: E151. doi: 10.3390/toxins10040151. Review.

5.

Creating a list of low-value health care interventions according to medical students perspective.

Bonnet R, Laurencet M, Gaspoz JM, Kherad O.

Eur J Intern Med. 2018 Jun;52:e41-e42. doi: 10.1016/j.ejim.2018.03.018. Epub 2018 Apr 4. No abstract available.

PMID:
29627119
6.

Extended-spectrum beta-lactamase (ESBL)- and carbapenemase-producing Enterobacteriaceae in water sources in Lebanon.

Diab M, Hamze M, Bonnet R, Saras E, Madec JY, Haenni M.

Vet Microbiol. 2018 Apr;217:97-103. doi: 10.1016/j.vetmic.2018.03.007. Epub 2018 Mar 10.

PMID:
29615264
7.

Emergence of plasmid-mediated colistin resistance (mcr-1) among Enterobacteriaceae strains: Laboratory detection of resistance and measures to control its dissemination.

Lepelletier D, Bonnet R, Plésiat P, Nicolas-Chanoine MH, Berger-Carbonne A, Chidiac C, Grandbastien B; national working group from the French High Council of Public Health.

Med Mal Infect. 2018 Jun;48(4):250-255. doi: 10.1016/j.medmal.2018.01.010. Epub 2018 Feb 21.

PMID:
29475568
8.

Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.

Cougnoux A, Movassaghi M, Picache JA, Iben JR, Navid F, Salman A, Martin K, Farhat NY, Cluzeau C, Tseng WC, Burkert K, Sojka C, Wassif CA, Cawley NX, Bonnet R, Porter FD.

Dig Dis Sci. 2018 Apr;63(4):870-880. doi: 10.1007/s10620-018-4914-x. Epub 2018 Jan 22.

PMID:
29357083
9.

Epidemic spread of Escherichia coli ST744 isolates carrying mcr-3 and blaCTX-M-55 in cattle in France.

Haenni M, Beyrouthy R, Lupo A, Châtre P, Madec JY, Bonnet R.

J Antimicrob Chemother. 2018 Feb 1;73(2):533-536. doi: 10.1093/jac/dkx418. No abstract available.

PMID:
29182716
10.

Maximize the impacts of space science.

Wu J, Bonnet R.

Nature. 2017 Nov 23;551(7681):435-436. doi: 10.1038/d41586-017-05995-6. No abstract available.

PMID:
29168841
11.

OXA-48 and CTX-M-15 extended-spectrum beta-lactamases in raw milk in Lebanon: epidemic spread of dominant Klebsiella pneumoniae clones.

Diab M, Hamze M, Bonnet R, Saras E, Madec JY, Haenni M.

J Med Microbiol. 2017 Nov;66(11):1688-1691. doi: 10.1099/jmm.0.000620. Epub 2017 Oct 17.

PMID:
29039302
12.

Accuracy of a rapid intrapartum group B Streptococcus test: A new immunochromatographic assay.

Delabaere A, Curinier S, Ughetto S, Gibold L, Bonnet R, Rossi A, Gallot D.

J Gynecol Obstet Hum Reprod. 2017 May;46(5):449-453. doi: 10.1016/j.jogoh.2017.03.010. Epub 2017 Apr 5.

PMID:
28934088
13.

Fortuitous Detection of cmy-2 and dha-1 from ESBL-producing Escherichia coli in Senegal.

Lo S, Robin F, Ba-Diallo A, Diallo OF, Dia ML, Beyrouthy R, Gaye-Diallo A, Sow AI, Bonnet R.

Bull Soc Pathol Exot. 2017 Oct;110(4):221-223. doi: 10.1007/s13149-017-0573-y. Epub 2017 Sep 8.

PMID:
28887772
14.

MCR-1 and OXA-48 In Vivo Acquisition in KPC-Producing Escherichia coli after Colistin Treatment.

Beyrouthy R, Robin F, Lessene A, Lacombat I, Dortet L, Naas T, Ponties V, Bonnet R.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e02540-16. doi: 10.1128/AAC.02540-16. Print 2017 Aug.

15.

mcr-1 Colistin Resistance in ESBL-Producing Klebsiella pneumoniae, France.

Caspar Y, Maillet M, Pavese P, Francony G, Brion JP, Mallaret MR, Bonnet R, Robin F, Beyrouthy R, Maurin M.

Emerg Infect Dis. 2017 May;23(5):874-876. doi: 10.3201/eid2305.161942.

16.

Biochemical characterization of CTX-M-166, a new CTX-M β-lactamase produced by a commensal Escherichia coli isolate.

Manageiro V, Graça R, Ferreira E, Clemente L, Bonnet R, Caniça M.

J Antibiot (Tokyo). 2017 Jun;70(6):809-810. doi: 10.1038/ja.2017.42. Epub 2017 Apr 5. No abstract available.

PMID:
28377638
17.

Emergence of a novel Enterobacter kobei clone carrying chromosomal-encoded CTX-M-12 with diversified pathogenicity in northeast China.

Zhou K, Yu W, Bonnet R, Cattoir V, Shen P, Wang B, Rossen JW, Xiao Y.

New Microbes New Infect. 2017 Jan 24;17:7-10. doi: 10.1016/j.nmni.2017.01.006. eCollection 2017 May. No abstract available.

18.

Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer.

Gagnière J, Bonnin V, Jarrousse AS, Cardamone E, Agus A, Uhrhammer N, Sauvanet P, Déchelotte P, Barnich N, Bonnet R, Pezet D, Bonnet M.

Clin Sci (Lond). 2017 Mar 1;131(6):471-485. doi: 10.1042/CS20160876. Epub 2017 Jan 16.

PMID:
28093453
19.

MCR-1 in ESBL-producing Escherichia coli responsible for human infections in New Caledonia.

Robin F, Beyrouthy R, Colot J, Saint-Sardos P, Berger-Carbonne A, Dalmasso G, Delmas J, Bonnet R.

J Antimicrob Chemother. 2017 Mar 1;72(3):946-947. doi: 10.1093/jac/dkw508. No abstract available.

PMID:
28031275
20.

Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.

Robin F, Beyrouthy R, Bonacorsi S, Aissa N, Bret L, Brieu N, Cattoir V, Chapuis A, Chardon H, Degand N, Doucet-Populaire F, Dubois V, Fortineau N, Grillon A, Lanotte P, Leyssene D, Patry I, Podglajen I, Recule C, Ros A, Colomb-Cotinat M, Ponties V, Ploy MC, Bonnet R.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01911-16. doi: 10.1128/AAC.01911-16. Print 2017 Mar.

21.

IncFIIk plasmid harbouring an amplification of 16S rRNA methyltransferase-encoding gene rmtH associated with mobile element ISCR2.

Beyrouthy R, Robin F, Hamze M, Bonnet R.

J Antimicrob Chemother. 2017 Feb;72(2):402-406. doi: 10.1093/jac/dkw435. Epub 2016 Oct 28.

PMID:
27793962
22.

Antibiotic Activity of Escherichia coli against Multiresistant Staphylococcus aureus.

Faïs T, Cougnoux A, Dalmasso G, Laurent F, Delmas J, Bonnet R.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6986-6988. doi: 10.1128/AAC.00130-16. Print 2016 Nov. No abstract available.

23.

Three-dimensional cone-beam CT sialography in non tumour salivary pathologies: procedure and results.

Bertin H, Bonnet R, Delemazure AS, Mourrain-Langlois E, Mercier J, Corre P.

Dentomaxillofac Radiol. 2017 Jan;46(1):20150431. Epub 2016 Sep 23.

24.

Rapid detection of AAC(6')-Ib-cr production using a MALDI-TOF MS strategy.

Pardo CA, Tan RN, Hennequin C, Beyrouthy R, Bonnet R, Robin F.

Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):2047-2051. Epub 2016 Aug 24.

PMID:
27558110
25.

Impact of CDT Toxin on Human Diseases.

Faïs T, Delmas J, Serres A, Bonnet R, Dalmasso G.

Toxins (Basel). 2016 Jul 15;8(7). pii: E220. doi: 10.3390/toxins8070220. Review.

26.

Targeting colorectal cancer-associated bacteria: A new area of research for personalized treatments.

Faïs T, Delmas J, Cougnoux A, Dalmasso G, Bonnet R.

Gut Microbes. 2016 Jul 3;7(4):329-333. Epub 2016 Mar 23.

27.

[Clinical Aspects of Cochlear Implantation in Meniere's Disease and After Labyrinthectomy].

Lehner AA, Bonnet R, Linder TE.

Laryngorhinootologie. 2016 Dec;95(12):831-836. doi: 10.1055/s-0042-100283. Epub 2016 Mar 18. German.

PMID:
26990936
28.

[How some commensal bacteria would exacerbate colorectal carcinogenesis?].

Raisch J, Dalmasso G, Bonnet R, Barnich N, Bonnet M, Bringer MA.

Med Sci (Paris). 2016 Feb;32(2):175-82. doi: 10.1051/medsci/20163202011. Epub 2016 Mar 2. Review. French.

29.

Gut microbiota imbalance and colorectal cancer.

Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M.

World J Gastroenterol. 2016 Jan 14;22(2):501-18. doi: 10.3748/wjg.v22.i2.501. Review.

30.

Charge transport through one-dimensional Moiré crystals.

Bonnet R, Lherbier A, Barraud C, Della Rocca ML, Lafarge P, Charlier JC.

Sci Rep. 2016 Jan 20;6:19701. doi: 10.1038/srep19701.

31.

Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation.

Agus A, Denizot J, Thévenot J, Martinez-Medina M, Massier S, Sauvanet P, Bernalier-Donadille A, Denis S, Hofman P, Bonnet R, Billard E, Barnich N.

Sci Rep. 2016 Jan 8;6:19032. doi: 10.1038/srep19032.

32.

[HIV sleeping, sleeping...].

Arm JY, Bonnet R, Gercekci C, Ndengera M, Wyssa BO, Cosson P, Soulié P.

Rev Med Suisse. 2015 Oct 7;11(489):1863-4. French. No abstract available.

PMID:
26638518
33.

Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn's Disease.

Sivignon A, Yan X, Alvarez Dorta D, Bonnet R, Bouckaert J, Fleury E, Bernard J, Gouin SG, Darfeuille-Michaud A, Barnich N.

MBio. 2015 Nov 17;6(6):e01298-15. doi: 10.1128/mBio.01298-15.

34.

Structural insights into the loss of penicillinase and the gain of ceftazidimase activities by OXA-145 β-lactamase in Pseudomonas aeruginosa.

Meziane-Cherif D, Bonnet R, Haouz A, Courvalin P.

J Antimicrob Chemother. 2016 Feb;71(2):395-402. doi: 10.1093/jac/dkv375. Epub 2015 Nov 14.

PMID:
26568564
35.

Escherichia coli ClbS is a colibactin resistance protein.

Bossuet-Greif N, Dubois D, Petit C, Tronnet S, Martin P, Bonnet R, Oswald E, Nougayrède JP.

Mol Microbiol. 2016 Mar;99(5):897-908. doi: 10.1111/mmi.13272. Epub 2015 Dec 1.

36.

The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli.

Gibold L, Garenaux E, Dalmasso G, Gallucci C, Cia D, Mottet-Auselo B, Faïs T, Darfeuille-Michaud A, Nguyen HT, Barnich N, Bonnet R, Delmas J.

Cell Microbiol. 2016 May;18(5):617-31. doi: 10.1111/cmi.12539. Epub 2015 Nov 23.

PMID:
26499863
37.

Antibiotic Resistance, Virulence, and Genetic Background of Community-Acquired Uropathogenic Escherichia coli from Algeria.

Yahiaoui M, Robin F, Bakour R, Hamidi M, Bonnet R, Messai Y.

Microb Drug Resist. 2015 Oct;21(5):516-26. doi: 10.1089/mdr.2015.0045. Epub 2015 Jun 1.

PMID:
26430940
38.

"Mind the Gap": Raman Evidence for Rapid Inactivation of CTX-M-9 β-Lactamase Using Mechanism-Based Inhibitors that Bridge the Active Site.

Heidari-Torkabadi H, Bethel CR, Ding Z, Pusztai-Carey M, Bonnet R, Bonomo RA, Carey PR.

J Am Chem Soc. 2015 Oct 14;137(40):12760-3. doi: 10.1021/jacs.5b10007. Epub 2015 Oct 5.

PMID:
26421661
39.

[The anterior tarsal tunnel syndrome: a case report].

Milants C, Wang FC, Gomulinski L, Ledon F, Petrover D, Bonnet R, Crielaard JM, Kaux JF.

Rev Med Liege. 2015 Jul-Aug;70(7-8):400-4. French.

40.

[Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis].

Behr J, Bonella F, Bonnet R, Gläser S, Grohé C, Günther A, Koschel D, Kreuter M, Kirsten D, Krögel C, Markart P, Müller-Quernheim J, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Wirtz H, Witt C, Costabel U.

Pneumologie. 2015 Aug;69(8):455-8. doi: 10.1055/s-0034-1392602. Epub 2015 Jul 30. German.

PMID:
26227628
41.

Genetic, biochemical characterization and mutagenesis of the chromosomal class A β-lactamase of Raoultella (formerly Klebsiella) terrigena.

Walckenaer E, Delmas J, Leflon-Guibout V, Bonnet R, Nicolas-Chanoine MH.

Pathol Biol (Paris). 2015 Sep;63(4-5):158-63. doi: 10.1016/j.patbio.2015.05.002. Epub 2015 Jun 16.

PMID:
26092758
42.

Two novel CMY-2-type β-lactamases encountered in clinical Escherichia coli isolates.

Manageiro V, Ferreira E, Pinto M, Fonseca F, Ferreira M, Bonnet R, Caniça M.

Ann Clin Microbiol Antimicrob. 2015 Mar 18;14:12. doi: 10.1186/s12941-015-0070-8.

43.

Predictive value of the usual clinical signs and laboratory tests in the diagnosis of septic arthritis.

Couderc M, Pereira B, Mathieu S, Schmidt J, Lesens O, Bonnet R, Soubrier M, Dubost JJ.

CJEM. 2015 Jul;17(4):403-10. doi: 10.1017/cem.2014.56. Epub 2015 Mar 30.

PMID:
25819038
44.

Construction of anti-parallel G-quadruplexes through sequential templated click.

Bonnet R, Lavergne T, Gennaro B, Spinelli N, Defrancq E.

Chem Commun (Camb). 2015 Mar 21;51(23):4850-3. doi: 10.1039/c4cc09744k.

PMID:
25695596
45.

Erratum: Covalent docking of large libraries for the discovery of chemical probes.

London N, Miller RM, Krishnan S, Uchida K, Irwin JJ, Eidam O, Gibold L, Cimermančič P, Bonnet R, Shoichet BK, Taunton J.

Nat Chem Biol. 2015 Mar;11(3):235. doi: 10.1038/nchembio0315-235b. No abstract available.

PMID:
25689339
46.

Analysis of the σE regulon in Crohn's disease-associated Escherichia coli revealed involvement of the waaWVL operon in biofilm formation.

Chassaing B, Garénaux E, Carriere J, Rolhion N, Guérardel Y, Barnich N, Bonnet R, Darfeuille-Michaud A.

J Bacteriol. 2015 Apr;197(8):1451-65. doi: 10.1128/JB.02499-14. Epub 2015 Feb 9.

47.

Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.

Cougnoux A, Delmas J, Gibold L, Faïs T, Romagnoli C, Robin F, Cuevas-Ramos G, Oswald E, Darfeuille-Michaud A, Prati F, Dalmasso G, Bonnet R.

Gut. 2016 Feb;65(2):278-85. doi: 10.1136/gutjnl-2014-307241. Epub 2015 Jan 14.

PMID:
25588406
48.

The MAST® D68C test: an interesting tool for detecting extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.

Nourrisson C, Tan RN, Hennequin C, Gibold L, Bonnet R, Robin F.

Eur J Clin Microbiol Infect Dis. 2015 May;34(5):975-83. doi: 10.1007/s10096-014-2305-6. Epub 2015 Jan 14.

PMID:
25586825
49.

The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment.

Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R.

Gut Microbes. 2014;5(5):675-80. doi: 10.4161/19490976.2014.969989.

50.

Evaluation of the efficiency of cefoxitin/cefepime combination against Enterobacteriaceae resistant to expanded-spectrum cephalosporins.

Serres A, Gibold L, Dalmasso G, Robin F, Bonnet R, Delmas J.

Int J Antimicrob Agents. 2015 Jan;45(1):86-7. doi: 10.1016/j.ijantimicag.2014.10.001. Epub 2014 Oct 22. No abstract available.

PMID:
25459401

Supplemental Content

Loading ...
Support Center